Public Health Trace republishes official recall, outbreak, and surveillance data from CDC, FDA, USDA,
WHO, and other public sources. It is an independent information service, not a medical provider, and
not a substitute for professional medical advice or your local public health department's own guidance.
Policy version 2026-07-21, effective July 21, 2026.
If you are experiencing a medical emergency, call your local emergency services immediately. For food
recalls and disease investigations, always refer to the official CDC, FDA, USDA, WHO, or your local
public health authority for the most current information.
Every FDA drug enforcement recall Public Health Trace has on record, republished from
openFDA's official drug enforcement database. See Health
Alerts for current, active recalls alongside outbreaks and advisories.
Drug recall information is sourced from the FDA's structured openFDA Enforcement
Reports. Newly announced recalls may appear on FDA.gov before they become available in
the structured dataset. See Methodology for how Public
Health Trace imports and refreshes this data.
Filters
Showing 10,041–10,060 of 17,974 drug recalls
Drug RecallTerminatedHistorical recordClass I
Power V8 Viagra tablets, 200mg, 10-Grain bottle, labeling is in foreign language
by A&H Focal Inc.
Reason
Marked Without An Approved NDA/ANDA: FDA analysis found these products to contain sildenafil, an FDA approved drug for the treatment of erectile dysfunction, making these products unapproved drugs for which safety and efficacy have not been establish and therefore, subject to recall.
Recall initiated
March 7, 2017
Reported by FDA
February 7, 2018
Distribution
NY and NJ through six retail stores named "Asian Food Markets"
YANSHIJIAONANG capsules, 2000mg, 8-count bottle, labeling is in foreign language
by A&H Focal Inc.
Reason
Marked Without An Approved NDA/ANDA: FDA analysis found these products to contain sildenafil, an FDA approved drug for the treatment of erectile dysfunction, making these products unapproved drugs for which safety and efficacy have not been establish and therefore, subject to recall.
Recall initiated
March 7, 2017
Reported by FDA
February 7, 2018
Distribution
NY and NJ through six retail stores named "Asian Food Markets"
HU HU SHENG WEI capsules, 3000 mg, 2-count bottle, labeling is in foreign language
by A&H Focal Inc.
Reason
Marked Without An Approved NDA/ANDA: FDA analysis found these products to contain sildenafil, an FDA approved drug for the treatment of erectile dysfunction, making these products unapproved drugs for which safety and efficacy have not been establish and therefore, subject to recall.
Recall initiated
March 7, 2017
Reported by FDA
February 7, 2018
Distribution
NY and NJ through six retail stores named "Asian Food Markets"
MAX MAN capsules, 3000 mg, 6-count bottle, labeling is in foreign language
by A&H Focal Inc.
Reason
Marked Without An Approved NDA/ANDA: FDA analysis found these products to contain sildenafil, an FDA approved drug for the treatment of erectile dysfunction, making these products unapproved drugs for which safety and efficacy have not been establish and therefore, subject to recall.
Recall initiated
March 7, 2017
Reported by FDA
February 7, 2018
Distribution
NY and NJ through six retail stores named "Asian Food Markets"
STREE OVERLORD capsules, 3800 mg, 4-count bottle, labeling is in foreign language
by A&H Focal Inc.
Reason
Marked Without An Approved NDA/ANDA: FDA analysis found these products to contain sildenafil, an FDA approved drug for the treatment of erectile dysfunction, making these products unapproved drugs for which safety and efficacy have not been establish and therefore, subject to recall.
Recall initiated
March 7, 2017
Reported by FDA
February 7, 2018
Distribution
NY and NJ through six retail stores named "Asian Food Markets"
Zhonghua Niubian tablets, 2000mg, 6-count bottle, labeling is in foreign language
by A&H Focal Inc.
Reason
Marked Without An Approved NDA/ANDA: FDA analysis found these products to contain sildenafil, an FDA approved drug for the treatment of erectile dysfunction, making these products unapproved drugs for which safety and efficacy have not been establish and therefore, subject to recall.
Recall initiated
March 7, 2017
Reported by FDA
February 7, 2018
Distribution
NY and NJ through six retail stores named "Asian Food Markets"
ZHANSHENG WEIGE CHAOYUE XILISHI tablets, 2000 mg, 6-count bottle, labeling is in foreign language
by A&H Focal Inc.
Reason
Marked Without An Approved NDA/ANDA: FDA analysis found these products to contain sildenafil, an FDA approved drug for the treatment of erectile dysfunction, making these products unapproved drugs for which safety and efficacy have not been establish and therefore, subject to recall.
Recall initiated
March 7, 2017
Reported by FDA
February 7, 2018
Distribution
NY and NJ through six retail stores named "Asian Food Markets"
Ye Lang Shen capsules, 5000 mg, 8-count bottle, labeling is in foreign language
by A&H Focal Inc.
Reason
Marked Without An Approved NDA/ANDA: FDA analysis found these products to contain sildenafil, an FDA approved drug for the treatment of erectile dysfunction, making these products unapproved drugs for which safety and efficacy have not been establish and therefore, subject to recall.
Recall initiated
March 7, 2017
Reported by FDA
February 7, 2018
Distribution
NY and NJ through six retail stores named "Asian Food Markets"
Clalis capsules, 50mg, 6-count bottle, labeling is in foreign language
by A&H Focal Inc.
Reason
Marked Without An Approved NDA/ANDA: FDA analysis found these products to contain sildenafil, an FDA approved drug for the treatment of erectile dysfunction, making these products unapproved drugs for which safety and efficacy have not been establish and therefore, subject to recall.
Recall initiated
March 7, 2017
Reported by FDA
February 7, 2018
Distribution
NY and NJ through six retail stores named "Asian Food Markets"
GOLD VIGRA capsules, 50mg, 6-count bottle, labeling is in foreign language
by A&H Focal Inc.
Reason
Marked Without An Approved NDA/ANDA: FDA analysis found these products to contain sildenafil, an FDA approved drug for the treatment of erectile dysfunction, making these products unapproved drugs for which safety and efficacy have not been establish and therefore, subject to recall.
Recall initiated
March 7, 2017
Reported by FDA
February 7, 2018
Distribution
NY and NJ through six retail stores named "Asian Food Markets"
LANG YI HAO CHAONONGSUOPIAN tablets, 500 mg, 8-count bottle, labeling is in foreign language
by A&H Focal Inc.
Reason
Marked Without An Approved NDA/ANDA: FDA analysis found these products to contain sildenafil, an FDA approved drug for the treatment of erectile dysfunction, making these products unapproved drugs for which safety and efficacy have not been establish and therefore, subject to recall.
Recall initiated
March 7, 2017
Reported by FDA
February 7, 2018
Distribution
NY and NJ through six retail stores named "Asian Food Markets"
HARD TEN DAYS capsules, 4500mg, 6-count bottle, labeling is in foreign language
by A&H Focal Inc.
Reason
Marked Without An Approved NDA/ANDA: FDA analysis found these products to contain sildenafil, an FDA approved drug for the treatment of erectile dysfunction, making these products unapproved drugs for which safety and efficacy have not been establish and therefore, subject to recall.
Recall initiated
March 7, 2017
Reported by FDA
February 7, 2018
Distribution
NY and NJ through six retail stores named "Asian Food Markets"
GERMANY NIUBIAN tablets, 3000mg, 10-count bottle, labeling is in foreign language
by A&H Focal Inc.
Reason
Marked Without An Approved NDA/ANDA: FDA analysis found these products to contain sildenafil, an FDA approved drug for the treatment of erectile dysfunction, making these products unapproved drugs for which safety and efficacy have not been establish and therefore, subject to recall.
Recall initiated
March 7, 2017
Reported by FDA
February 7, 2018
Distribution
NY and NJ through six retail stores named "Asian Food Markets"
GERMANY BLACK GOLD tablets, 2800 mg, 8-count bottle, labeling is in foreign language
by A&H Focal Inc.
Reason
Marked Without An Approved NDA/ANDA: FDA analysis found these products to contain sildenafil, an FDA approved drug for the treatment of erectile dysfunction, making these products unapproved drugs for which safety and efficacy have not been establish and therefore, subject to recall.
Recall initiated
March 7, 2017
Reported by FDA
February 7, 2018
Distribution
NY and NJ through six retail stores named "Asian Food Markets"
Miraculous Evil Root capsules, 1200 mg, 6-count bottle, labeling is in foreign language
by A&H Focal Inc.
Reason
Marked Without An Approved NDA/ANDA: FDA analysis found these products to contain sildenafil, an FDA approved drug for the treatment of erectile dysfunction, making these products unapproved drugs for which safety and efficacy have not been establish and therefore, subject to recall.
Recall initiated
March 7, 2017
Reported by FDA
February 7, 2018
Distribution
NY and NJ through six retail stores named "Asian Food Markets"
Indian God Lotion Spray Bottle, labeling is in foreign language
by A&H Focal Inc.
Reason
Marked Without An Approved NDA/ANDA: FDA analysis found this product to contain diethyl phthalate, an inactive ingredient in several modified release solid oral dosage forms, making this product unapproved drug for which safety and efficacy have not been establish and therefore, subject to recall.
Recall initiated
March 7, 2017
Reported by FDA
February 7, 2018
Distribution
NY and NJ through six retail stores named "Asian Food Markets"
Black Ant capsules, 4600mg, 4-count blister pack, labeling is in foreign language
by A&H Focal Inc.
Reason
Marked Without An Approved NDA/ANDA: FDA analysis found these products to contain sildenafil, an FDA approved drug for the treatment of erectile dysfunction, making these products unapproved drugs for which safety and efficacy have not been establish and therefore, subject to recall.
Recall initiated
March 7, 2017
Reported by FDA
February 7, 2018
Distribution
NY and NJ through six retail stores named "Asian Food Markets"
This information is republished from FDA's Recall Enterprise System through openFDA. Public Health Trace
does not verify or supplement it, is not affiliated with the FDA, and does not provide medical advice --
always follow the guidance of your pharmacist, physician, or the recalling company for any medication you take.
Read the full medical disclaimer.
